Intervention for Teens with ADHD and Substance Use
对患有多动症和药物滥用的青少年进行干预
基本信息
- 批准号:8631364
- 负责人:
- 金额:$ 58.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-09 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AbateAbstinenceAchievementAcuteAddressAdolescentAdultAffectAlcohol or Other Drugs useAlcoholsAttention deficit hyperactivity disorderBehavior DisordersCigaretteCognitiveCognitive TherapyConflict (Psychology)Control GroupsDevelopmentDiseaseEarly InterventionEffectivenessEnrollmentEvaluationFamilyFloridaFutureGoalsGuidelinesIllicit DrugsImpairmentIndividualInterventionIntervention StudiesLiteratureMaintenanceMinorityMonitorMotivationOutcomeParentsParticipantPharmaceutical PreparationsPopulationPreventive InterventionPsychiatric DiagnosisRandomizedRecruitment ActivityRelative (related person)ResearchRiskRisk FactorsSelf EfficacySubstance AddictionSubstance Use DisorderSubstance abuse problemTeenagersTestingTimeTrainingadolescent substance usebrief interventiondeviantearly onset substance useevidence basehigh riskhigh risk sexual behaviorimprovedmeetingsparental monitoringpeerprimary outcomepsychosocialpublic health relevanceresponsesecondary outcometherapy developmenttreatment adherencetreatment effecttreatment response
项目摘要
DESCRIPTION (provided by applicant): Individuals with ADHD are at markedly high risk for increased substance use and Substance Use Disorder (SUD; Barkley et al., 2004; Charach et al, 2011; Derefinko & Pelham, in press; Lee et al., 2011; Molina & Pelham, 2003; Sibley et al., 2011). They have high rates of substance use across a wide range of substances, including illicit drugs, alcohol, and cigarettes (Arias et al., 2008; Molina & Pelham, 2003; Szobot et al., 2007), and are at risk for early onset of substance use behaviors and disorders (Arias et al., 2008; Milberger et al.,1997; Molina & Pelham, 2003). Importantly, these substance use problems do not abate over time; among individuals with adult ADHD, rates of substance use disorders approach 40% (Kalbag & Levin, 2005; Biederman et al., 1995), suggesting the need for early intervention. However, treatment of ADHD and substance use concurrently presents a number of problems for clinicians, including poor treatment adherence, lack of treatment progress, and impaired achievement of treatment goals, (Carroll & Rounsaville, 1993; Levin et al., 2004; Wise et al., 2001). Given these barriers, it is clear that future prevention and intervention development should follow the guidelines provided by the current literature on both ADHD and substance use treatment. Several psychosocial interventions for teens with SUD are well-established (Waldron & Turner, 2008; Winters & Leitten, 2007). However, typical studies that have examined efficacy of substance use interventions have conducted only secondary analyses to see if comorbid psychiatric diagnoses moderate outcome. There have been no controlled evaluations of how comorbid ADHD affects the efficacy of early intervention for early substance use. Given the strong evidence for the negative trajectory for individuals with co-occurring ADHD and substance use initiation, our goal is to conduct a controlled examination of a brief, early intervention for substance use (BEI; Teen Intervene, Winters & Leitten, 2007) modified for adolescents with ADHD by using the evidence from both treatment literatures. Importantly, this intervention will address individuals who have initiated substance use, but do not yet meet criteria for an SUD. Although brief interventions have been found to be effective in other populations, their efficacy in an ADHD population with emerging substance use remains uninvestigated. We expect BEI to be effective for some but not all ADHD teens, with lower rates of response than have been obtained with nonADHD populations. To better understand why some adolescents with ADHD and substance use initiation respond to BEI and others do not, we investigate the contributions of several cognitive, proximal and situational factors to treatment response. Finally, we will randomize non-responders to the BEI to three secondary treatment conditions (monitor only, parent training/adolescent cognitive behavioral therapy, and medication plus parent training/adolescent cognitive behavioral therapy) to determine the relative efficacy of these more intensive interventions for insufficient responders to brief treatment.
描述(由申请人提供):患有注意力缺陷多动症(ADHD)的个体物质使用增加和物质使用障碍的风险明显较高(SUD;Barkley 等人,2004 年;Charach 等人,2011 年;Derefinko 和 Pelham,出版中;Lee 等人,2011 年)。 ,2011;莫利纳和佩勒姆,2003;西布利等人,2011)。他们对多种物质的使用率很高,包括非法药物、酒精和香烟(Arias 等人,2008 年;Molina 和 Pelham,2003 年;Szobot 等人,2007 年),并且面临早期吸毒的风险。物质使用行为和障碍的发作(Arias 等人,2008 年;Milberger 等人,1997 年;Molina 和 Pelham, 2003)。重要的是,这些物质使用问题不会随着时间的推移而减轻;在患有成人 ADHD 的个体中,物质使用障碍的发生率接近 40%(Kalbag & Levin,2005;Biederman 等,1995),这表明需要早期干预。然而,ADHD 的治疗和药物滥用同时给临床医生带来了许多问题,包括治疗依从性差、治疗进展缓慢以及治疗目标的实现受损(Carroll & Ronsaville,1993;Levin 等,2004;Wise 等)等,2001)。考虑到这些障碍,很明显,未来的预防和干预措施的发展应遵循当前关于多动症和药物滥用治疗的文献提供的指南。针对 SUD 青少年的几种心理社会干预措施已经成熟(Waldron & Turner,2008;Winters & Leitten,2007)。然而,检查物质使用干预措施功效的典型研究仅进行了二次分析,以确定共病精神疾病诊断是否会影响结果。对于共病 ADHD 如何影响早期药物使用的早期干预效果,尚未进行对照评估。鉴于有强有力的证据表明同时发生 ADHD 和物质使用开始的个体的负面轨迹,我们的目标是对物质使用的简短、早期干预进行受控检查(BEI; Teen Intervene, Winters & Leitten, 2007)修改使用两种治疗文献中的证据来治疗患有多动症的青少年。重要的是,这项干预措施将针对那些已经开始使用药物但尚未达到 SUD 标准的个人。尽管已发现简短的干预措施对其他人群有效,但其对新出现药物滥用的 ADHD 人群的疗效仍未得到研究。我们预计 BEI 对部分但不是所有 ADHD 青少年有效,其反应率低于非 ADHD 人群的反应率。为了更好地理解为什么一些患有 ADHD 和物质使用开始的青少年对 BEI 有反应而其他人则没有,我们调查了几种认知、近端和情境因素对治疗反应的贡献。最后,我们将 BEI 无反应者随机分配到三种次要治疗条件(仅监测、家长培训/青少年认知行为治疗、药物加家长培训/青少年认知行为治疗),以确定这些更强化的干预措施的相对功效对短暂治疗的反应不足。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM E PELHAM其他文献
WILLIAM E PELHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM E PELHAM', 18)}}的其他基金
Training Program in Adolescent Substance Use Disorders and Co-Occurring Mental and Behavioral Disorders
青少年药物使用障碍和并发精神和行为障碍培训计划
- 批准号:
10381510 - 财政年份:2019
- 资助金额:
$ 58.8万 - 项目类别:
Training Program in Adolescent Substance Use Disorders and Co-Occurring Mental and Behavioral Disorders
青少年药物使用障碍和并发精神和行为障碍培训计划
- 批准号:
9905502 - 财政年份:2019
- 资助金额:
$ 58.8万 - 项目类别:
Improving Medication Adherence in ADHD Adolescents
提高多动症青少年的药物依从性
- 批准号:
8791345 - 财政年份:2014
- 资助金额:
$ 58.8万 - 项目类别:
Improving Medication Adherence in ADHD Adolescents
提高多动症青少年的药物依从性
- 批准号:
8631293 - 财政年份:2014
- 资助金额:
$ 58.8万 - 项目类别:
Examining Tolerance to CNS Stimulants in ADD
检查 ADD 患者对中枢神经系统兴奋剂的耐受性
- 批准号:
8506817 - 财政年份:2013
- 资助金额:
$ 58.8万 - 项目类别:
Examining Tolerance to CNS Stimulants in ADD
检查 ADD 患者对中枢神经系统兴奋剂的耐受性
- 批准号:
8653025 - 财政年份:2013
- 资助金额:
$ 58.8万 - 项目类别:
Examining Tolerance to CNS Stimulants in ADD
检查 ADD 患者对中枢神经系统兴奋剂的耐受性
- 批准号:
9002093 - 财政年份:2013
- 资助金额:
$ 58.8万 - 项目类别:
Examining Tolerance to CNS Stimulants in ADD
检查 ADD 患者对中枢神经系统兴奋剂的耐受性
- 批准号:
8814132 - 财政年份:2013
- 资助金额:
$ 58.8万 - 项目类别:
Increasing Academic Success in Middle School Students with ADHD
提高患有多动症的中学生的学业成功
- 批准号:
8244286 - 财政年份:2012
- 资助金额:
$ 58.8万 - 项目类别:
Increasing Academic Success in Middle School Students with ADHD
提高患有多动症的中学生的学业成功
- 批准号:
8607210 - 财政年份:2012
- 资助金额:
$ 58.8万 - 项目类别:
相似国自然基金
趋化因子CXCL14在胚胎植入中的作用及机制研究
- 批准号:30670785
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
人工泵式括约肌对去肛门括约肌犬节制排便的实验研究
- 批准号:39670706
- 批准年份:1996
- 资助金额:8.0 万元
- 项目类别:面上项目
相似海外基金
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
- 批准号:
10736443 - 财政年份:2023
- 资助金额:
$ 58.8万 - 项目类别:
Fentanyl use during pregnancy: impact on dam, placenta, and offspring development.
怀孕期间使用芬太尼:对母鼠、胎盘和后代发育的影响。
- 批准号:
10750077 - 财政年份:2023
- 资助金额:
$ 58.8万 - 项目类别:
Integrated Treatment for Enhancing Growth in Recovery during Adolescence (InTEGRA)
促进青春期恢复生长的综合治疗 (InTEGRA)
- 批准号:
10680616 - 财政年份:2023
- 资助金额:
$ 58.8万 - 项目类别:
Safety/Toxicology, ADME and CMC Activities to Support the Assessment of the mGlu2 PAM SBP-9330 in a Phase 2 Clinical Study in Smokers
支持在吸烟者 2 期临床研究中评估 mGlu2 PAM SBP-9330 的安全性/毒理学、ADME 和 CMC 活动
- 批准号:
10829189 - 财政年份:2023
- 资助金额:
$ 58.8万 - 项目类别:
VisitBoost: A Home Visiting Enhancement to Reduce Harm for Families Affected by Substance Misuse
VisitBoost:家访增强功能,可减少受药物滥用影响的家庭的伤害
- 批准号:
10602257 - 财政年份:2023
- 资助金额:
$ 58.8万 - 项目类别: